E70.339 Albinism with hematologic abnormality, unspecified

Name of the Condition

• Albinism with hematologic abnormality, unspecified (ICD-10-CM Code: E70.339)

Summary

Albinism with hematologic abnormality, unspecified is a genetic condition marked by reduced or absent melanin production, affecting skin, hair, and eye pigmentation, along with unspecified hematologic abnormalities. This condition may lead to vision problems due to abnormal optic nerve or retinal development, and hematologic findings may include anemia, leukopenia, or thrombocytopenia, though specific details are not documented.

Causes

Albinism with hematologic abnormality, unspecified results from genetic mutations that disrupt melanin synthesis or transport, often involving genes critical for both pigmentation and hematopoiesis. These mutations impair melanin production, a pigment essential for normal pigmentation and eye development, and may also affect blood cell formation, though the exact genetic basis is not specified.

Risk Factors

• Genetic inheritance; typically autosomal recessive, requiring mutations in both copies of a gene.
• Family history of albinism with hematologic abnormalities.
• Higher carrier rates in certain populations for specific genetic variants.

Symptoms

• Pale skin, light hair, and light-colored eyes.
• Vision issues, including nystagmus, strabismus, photophobia, and reduced visual acuity.
• Hematologic abnormalities, such as anemia, leukopenia, or thrombocytopenia.
• Increased susceptibility to sunburn and skin damage.

Diagnosis

Diagnosis involves a physical exam to assess pigmentation and hematologic signs, blood tests to evaluate blood cell counts, and genetic testing to identify mutations. Imaging or specialized tests may be used to assess vision or organ involvement, though specific details are not documented.

Treatment Options

Treatment focuses on managing symptoms and complications. This may include vision aids for eye problems, sun protection to prevent skin damage, and hematologic support (e.g., blood transfusions or medications) for blood abnormalities. Genetic counseling is often recommended.

Prognosis and Follow-Up

Prognosis varies depending on the severity of hematologic and vision issues. Regular follow-up with specialists (e.g., ophthalmologists, hematologists) is important to monitor and manage complications. Early intervention can improve quality of life.

Complications

• Severe vision impairment or blindness.
• Increased risk of skin cancer due to sun sensitivity.
• Complications from untreated hematologic abnormalities (e.g., bleeding, infection).

Lifestyle & Prevention

• Use sunscreen and protective clothing to reduce sunburn risk.
• Regular eye exams to monitor vision changes.
• Avoid activities with high injury risk if bleeding tendencies are present.

When to Seek Professional Help

Seek medical attention if experiencing sudden vision changes, unexplained bleeding, severe fatigue, or signs of infection. Prompt evaluation is important for managing complications.

Tips for Medical Coders

Document the presence of albinism and hematologic abnormalities clearly. Use E70.339 when the hematologic abnormality is unspecified. Ensure clinical documentation supports the diagnosis and differentiates it from other albinism subtypes.